Stephen Evans
Impact in
- Toxicology top 0.01%
- Pharmacovigilance and Adverse Drug Reactions
- Infectious Diseases top 0.2%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
Papers in
- Toxicology 39
- Pharmacovigilance and Adverse Drug Reactions 37
-
- Statistical Methods in Clinical Trials 22
- Statistical Methods in Epidemiology 11
- Co-authors
- Douglas G. Altman (6 shared papers)PATRICK C. WALLER (8 shared papers)Stuart Pocock (8 shared papers)Diana Ruth Elbourne (2 shared papers)Gilda GP Piaggio (2 shared papers)Andrew Bate (2 shared papers)Ian Douglas (26 shared papers)Liam L Smeeth (25 shared papers)
- Journals
- British Journal of Clinical Pharmacology (18 papers)Pharmacoepidemiology and Drug Safety (13 papers)The Lancet (11 papers)BMJ (11 papers)Drug Safety (8 papers)
- Partner nations
- United KingdomUnited StatesAustralia
In The Last Decade
Stephen Evans
284 papers receiving 23.5k citations
Stephen Evans's Hit Papers
Peers
Comparison fields: 5 of 190
- Toxicology 2.8k
- Infectious Diseases 4.7k
- Statistics, Probability and Uncertainty 1.2k
- Modeling and Simulation 731
- Statistics and Probability 1.3k
Countries citing papers authored by Stephen Evans
This map shows the geographic impact of Stephen Evans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Evans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Evans more than expected).
Fields of papers citing papers by Stephen Evans
This network shows the impact of papers produced by Stephen Evans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Evans. The network helps show where Stephen Evans may publish in the future.
Co-authors
The 25 scholars most cited alongside Stephen Evans, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 294 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Factors associated with COVID-19-related death using OpenSAFELY Hit paper breakdown → | 2020 | 4933 |
| 2 | Reporting of Noninferiority and Equivalence Randomized Trials Hit paper breakdown → | 2012 | 1530 |
| 3 | Interpretation of the evidence for the efficacy and safety of statin therapy Hit paper breakdown → | 2016 | 1457 |
| 4 | Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports Hit paper breakdown → | 2001 | 1390 |
| 5 | Better Reporting of Harms in Randomized Trials: An Extension of the CONSORT Statement Hit paper breakdown → | 2004 | 1225 |
| 6 | Reporting of Noninferiority and Equivalence Randomized Trials Hit paper breakdown → | 2006 | 964 |
| 7 | Quantitative signal detection using spontaneous ADR reporting Hit paper breakdown → | 2009 | 723 |
| 8 | Long COVID burden and risk factors in 10 UK longitudinal studies and electronic health records Hit paper breakdown → | 2022 | 421 |
| 9 | BMI and risk of dementia in two million people over two decades: a retrospective cohort study Hit paper breakdown → | 2015 | 386 |
| 10 | 2020 | 339 | |
| 11 | Ethnic differences in SARS-CoV-2 infection and COVID-19-related hospitalisation, intensive care unit admission, and death in 17 million adults in England: an observational cohort study using the OpenSAFELY platform Hit paper breakdown → | 2021 | 333 |
| 12 | 1995 | 308 | |
| 13 | 1999 | 297 | |
| 14 | 2016 | 247 | |
| 15 | 1988 | 229 | |
| 16 | 2007 | 222 | |
| 17 | 2020 | 220 | |
| 18 | 1998 | 207 | |
| 19 | 2008 | 201 | |
| 20 | 1989 | 198 |
About Stephen Evans
Stephen Evans is a scholar working on Toxicology, Statistics and Probability, Infectious Diseases, Statistics, Probability and Uncertainty and Cardiology and Cardiovascular Medicine, having authored 294 papers that have together received 24.8k indexed citations. Recurring topics across this work include Pharmacovigilance and Adverse Drug Reactions (37 papers), COVID-19 Clinical Research Studies (25 papers), Statistical Methods in Clinical Trials (22 papers), Meta-analysis and systematic reviews (19 papers), Statistical Methods in Epidemiology (11 papers), SARS-CoV-2 and COVID-19 Research (11 papers), Pharmaceutical industry and healthcare (10 papers) and Pregnancy and Medication Impact (9 papers). The work is most often cited by research in Toxicology (2.8k citations), Infectious Diseases (4.7k citations), Statistics, Probability and Uncertainty (1.2k citations), Modeling and Simulation (731 citations) and Statistics and Probability (1.3k citations). Stephen Evans has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Douglas G. Altman, PATRICK C. WALLER, Stuart Pocock, Diana Ruth Elbourne, Gilda GP Piaggio, Andrew Bate, Ian Douglas, Liam L Smeeth, Eva D. Alberman and Richard W. Smith. Their work appears in journals such as British Journal of Clinical Pharmacology, Pharmacoepidemiology and Drug Safety, The Lancet, BMJ and Drug Safety.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.